![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/zhejiang-doer-biologics-completes-enrollment-of-the-phase-1b2a-trial-evaluating-dr10624-in-obese-subjects-with-modest-hypertriglyceridemia-302189900.html
https://www.prnewswire.com/news-releases/doer-biologics-announces-first-subject-dosed-in-phase-i-12-week-multiple-ascending-dose-mad-clinical-trial-of-dr10624-and-received-ind-approval-from-nmpa-301890125.html